Aldeyra Therapeutics, Inc. Uncategorized Contracts & Agreements
16 Contracts & Agreements
- Open Market Sale AgreementSM by and between the Company and Jefferies LLC, dated August 1, 2024 (Filed With SEC on August 1, 2024)
- Offer Letter Amendment No. 2, effective as of March 23, 2021, between the Registrant and Stephen Machatha, Ph.D (Filed With SEC on March 17, 2022)
- Offer Letter Amendment No. 1, effective as of January 1, 2018, between the Registrant and Stephen Machatha, Ph.D (Filed With SEC on March 17, 2022)
- Offer Letter, effective as of October 21, 2015, between the Registrant and Stephen Machatha, Ph.D (Filed With SEC on March 17, 2022)
- Description of Securities (Filed With SEC on March 12, 2020)
- Offer Letter, effective as of April 19, 2018, between the Registrant and David McMullin (Filed With SEC on March 8, 2019)
- Open Market Sale AgreementSM, dated December 28, 2018, by and between Aldeyra Therapeutics, Inc. and Jefferies LLC (Filed With SEC on December 28, 2018)
- Offer Letter, effective as of July 30, 2018, between the Registrant and Joshua Reed (Filed With SEC on November 14, 2018)
- ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE, SUITE 320 LEXINGTON, MA 02421 December 15, 2015 (Filed With SEC on March 30, 2016)
- * * * * * (Filed With SEC on August 7, 2014)
- ALDEXA THERAPEUTICS, INC. February 19, 2014 (Filed With SEC on March 17, 2014)
- ALDEXA THERAPEUTICS, INC. February 19, 2014 (Filed With SEC on March 17, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on March 17, 2014)
- Shares (Filed With SEC on March 17, 2014)
- Shares (Filed With SEC on January 27, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on January 6, 2014)
